Olmesartan Medoxomil/Hydrochlorothiazide Krka (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Hydrochlorothiazide Krka, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartan Medoxomil/Hydrochlorothiazide Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil/Hydrochlorothiazide Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxil/Hydrochlorothiazide is indicated for hypertension management, targeting the renin‑angiotensin system and fluid balance.

- Hypertension: lowers blood pressure when used alone or with other antihypertensives. - Heart failure: assists in controlling fluid overload as part of combination therapy. - Diabetic nephropathy: helps reduce proteinuria and protect kidney function in patients with type 2 diabetes.

Common Side Effects: - Dizziness (often the most most ... ... ... ... ... ... ... ...) - Headache  - Fatigue  - Increased urine output  - Electrolyte imbalance (e.g., low potassium) - Mild dry cough 

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis or angio ... ... ... ... ... ...) - Acute kidney injury  - Significant drop in blood pressure (e.g., hypotension )...  - Liver damage (e ... ... ...  -  - 

Olmesartan Medoxil/H  

  lank \\